Drugmakers, compounders at odds over FDA’s difficult-to-compound rule

Regulatory NewsRegulatory NewsCompoundingMedical DevicesPharmaceuticalsProposed ruleRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)